Literature DB >> 12955671

Quality of life after kidney and pancreas transplantation: a review.

John T Joseph1, Lyndsay S Baines, Michael C Morris, Rahul M Jindal.   

Abstract

There is an increasing amount of data on quality of life (QOL) in most chronic illnesses; some of the instruments used are generic, but recently, there is a tendency to use disease-specific instruments. We propose that recipients of organ transplants be assessed routinely for QOL by means of the 36-Item Short-Form Health Survey or a disease-specific instrument; for compliance, by means of the Long-Term Medication Behavior Self-Efficacy Scale; and for psychological status, by means of the Beck Depression Inventory Brief Symptom Inventory or the Symptom Checklist. The widespread use of QOL data in recipients of organ transplants will increase accountability of service providers and eventually increase patient satisfaction because these instruments are patient reported.

Entities:  

Mesh:

Year:  2003        PMID: 12955671     DOI: 10.1016/s0272-6386(03)00740-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Social participation and employment status after kidney transplantation: a systematic review.

Authors:  Sijrike F van der Mei; Boudien Krol; Willem J van Son; Paul E de Jong; Johan W Groothoff; Wim J A van den Heuvel
Journal:  Qual Life Res       Date:  2006-08       Impact factor: 4.147

Review 2.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.

Authors:  Roger W Evans; William H Applegate; David M Briscoe; David J Cohen; Christopher C Rorick; Barbara T Murphy; Joren C Madsen
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 8.237

Review 4.  [Pancreas and islet transplantation. The role in the treatment of diabetes mellitus].

Authors:  P Schenker; R Viebahn
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

5.  Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany.

Authors:  Jan Steffen Jürgensen; Robert Ikenberg; Roger-Axel Greiner; Volker Hösel
Journal:  Eur J Health Econ       Date:  2014-04-13

6.  Crosssectional study of quality of life after renal transplant in end stage renal disease.

Authors:  R C Das; Kalpana Srivastava; Jayadev Tudu; A K Hooda
Journal:  Ind Psychiatry J       Date:  2014-01

7.  More Than 25 Years of Pancreas Graft Survival After Simultaneous Pancreas and Kidney Transplantation: Experience From the World's Largest Series of Long-term Survivors.

Authors:  Sandesh Parajuli; Natalie M Bath; Fahad Aziz; Neetika Garg; Brenda Muth; Arjang Djamali; Robert R Redfield; Dixon Kaufman; Jon Odorico; Didier Mandelbrot; Hans Sollinger
Journal:  Transplantation       Date:  2020-06       Impact factor: 4.939

Review 8.  The applications of bone marrow-derived stem cells to induce tolerance and chimerism in organ transplantation.

Authors:  M Ebrahimi; N Aghdami
Journal:  Int J Organ Transplant Med       Date:  2010

9.  Why take the chance? A qualitative grounded theory study of nocturnal haemodialysis recipients who decline kidney transplantation.

Authors:  Meagen M Rosenthal; Anita E Molzahn; Christopher T Chan; Sandra L Cockfield; S Joseph Kim; Robert P Pauly
Journal:  BMJ Open       Date:  2016-05-18       Impact factor: 2.692

10.  Patient-Centered mHealth Living Donor Transplant Education Program for African Americans: Development and Analysis.

Authors:  John Christopher Sieverdes; Lynne S Nemeth; Gayenell S Magwood; Prabhakar K Baliga; Kenneth D Chavin; Brenda Brunner-Jackson; Sachin K Patel; Kenneth J Ruggiero; Frank A Treiber
Journal:  JMIR Res Protoc       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.